Vol.
130,
July
31,
No. 2, 1985
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
1985
Pages
SELECTIVE
580-587
EFFECTS OF GOLD(II1) ON PARATHYROID HORMONE-, PROSTAGLANDIN E2AND GUANINE NUCLEOTIDE-SENSITIVE ADENYLATE CYCLASE F. van Valen,
Medizinische
Received
June
H. Franck,
H.L.
Klinik und Poliklinik 4000 Dusseldorf
Kriiskemper
and E. Keck
C der Universitst 1, West Germany
DUsseldorf,
14, 1985
SUMMARY: Gold(II1) (Au(III)) up to 0.25 nM increased parathyroid hormoneand prostaglandin E2 -sensitive chick osteoblast adenylate cyclase activity without affecting 5'-guanylylimidodiphosphate-stimulated enzyme activity. Au(II1) at 5-50 uM inhibited hormoneand nucleotidemediated activation of adenylate cyclase. Basal adenylate cyclase activity was not influenced by Au(II1) in the given concentrations. Treatment of membranes with 5'-guanylylimidodiphosphate prior to incubation with Au(III) prevented the inhibitory effect of Au(II1) on adenylate cyclase. Our data suggest that Au(II1) alters the response of adenylate cyclase to agonists most likely through interaction with specific sulfhydryl groups associated with the enzyme system. 0 1985 Academic Press,
Inc.
It
is
cyclase
believed
that
(ATP pyrophosphate-lyase
composed the
generally
of at least
guanine
component
three
the
distinct
proteins:
of ATP to cyclic
of the enzyme system
depends
on the complex
components.
studies
have been
proteins.
The sites
gold
compounds
proteins
are
have been zymes (3-5). pounds
with thought
shown to inhibit
responsive
reports
The activation
of Au(III)
between
these
interaction
of
of gold
(2,3).
Gold
is
still
on adenylate
with
complexes
of a variety
on the action cyclase
is
and the catalytic
on the
activity
information
the effects
receptor,
interactions
moieties
adenylate
the hormone
of interaction
the biologic
To our knowledge,
on hormone
communication
to be sulfhydryl
system
AMP (1).
reported
adenylate
EC 4.6.1.1)
component,
regulatory
conversion
Numerous
responsive
(cyclizing),
nucleotide-binding for
the hormone
of en-
of gold lacking. cyclase
comThis in
Au(III), chloroauric acid; hPTH l-34, human ABBREVIATIONS: gold(III), parathyroid hormone N-terminal peptide; PGE , prostaglandin E2; GppNHp, 5'-guanylylimidodiphosphate; NEM, N-ethylmafeimide. 0006-291X/85 $1.50 Copyright 0 I985 by Academic Press, Inc. All rights of reproduction in any form reserved.
580
Vol.
130,
BIOCHEMICAL
No. 2, 1985
response pares
to hPTH its
agent.
with
The system
chick
osteoblast
and which cyclase. lationship cyclase
for
this
membranes,
has typical
that
(GppNHp),
Au(III)
is
and comalkylating
was the adenylate
cyclase
by hPTH
of hormone
functional
COMMUNICATIONS
sulfhydryl
is activated
characteristics
of the various
nucleotide
study
which
indicate
RESEARCH
of NEM, a well-known
those
chosen
Our data
BIOPHYSICAL
PGE2, and guanine
l-34,
effects
AND
and PGE2
l-34
responsive
useful
components
from
adenylate
in probing
the re-
of the adenylate
system.
METHODS Osteoblast-like bone cells were isolated from 18-day-old chick embryo calvaria with collagenase (1 mg/ml isolation medium (6)) by the method of Nijweide et al. (7). Cell cult ures were maintained in Costar T-150 flasks in DMEM supplemented with 10% fetal calf serum, 200 ug/ml glutamine and 50 ug/ml gentamycin sulfate. Cultures were kept at 37°C with 5% CO2 for 6-7 days before being used. Osteoblast membranes were prepared as described recently (8). Adenylate cyclase was assayed in a reaction mixture containing 10 mM Na-acetate buffer pH 7.4, 0.5 mM ATP, 5 mM M&12, 5 mM creatine phosphate, 6.2 U/ml creatine phosphokinase, and 250 ug/ml membrane protein. Test substances were added at concentrations as warranted by individual experiments. When hormone was present in the assay mixture, GppNHp (200 JJM) was also included. hPTH l-34 (2600 U/mg; Bachem) and PGE (Sigma) were dissolved in 0.001 N HCl and ethanol, respectively, and 2.iluted in buffer just prior to assay. Solutions of Au(II1) (HAuC14.3 H 0; Au content min. 49%; Merck) were always prepared fresh in 0.001 N HC? and used within 15 min of an experiment. Membranes were preincubated with Au(III) or NEM for 30 min at 37°C in the assay buffer. Pretreatment of membranes with GppNHp (200 uM) was performed in 10 mM Tris-HCl pH 7.4 with 5 mM MgC12 for 20 min. Enzyme reactions were started by addition of ATP and were conducted for 20 min at 37°C. Preliminary studies showed that, under the assay conditions employed here, cyclic AMP formation was linear over this time period. Incubations were terminated with n-propanol (9) and cyclic AMP was measured with the Amersham International assay kit. Protein was determined by the method of Lowry et al. (10)
--RESULTS The dose response stimulated in Fig.
1. Au(II1)
cyclase, found
adenylate
with
curve cyclase
stimulated
a maximal
centrations adenylate
of Au(II1) cyclase
on basal,
activities
in osteoblast
at 0.25
enzyme activity inhibited
activity.
hPTH
hPTH 1-34-mediated
effect
when PGE2-stimulated
of Au(II1)
uM
membranes
activation
was measured.
581
total
is
shown
of adenylate
The same maximum was
Au(II1).
hPTH I-34-sensitive
Essentially,
and PGE2-
l-34-,
inhibition
Increasing
and PGE -sensitive 2
of hormone-
con-
Vol.
130,
No. 2, 1985
BIOCHEMICAL
AND
BIOPHYSICAL
01a,-6 . -7 -6
RESEARCH
-5
-4 Au(III)
COMMUNICATIONS
* (M)
1. Concentration-effect curve for Au(II1) on adenylate cyclase Fig. activity in the absence (+) and presence of 5 rig/ml hPTH 1-34 (A) or 10 pM PGE2 (e). Other conditions were as described under 'Methods'. Values are the means of duplicate determinations in 3 separate experiments.
sensitive
enzyme
Basal
adenylate
Au(II1)
tested The
0
up of of
1
50
10
was
in not
the
presence
of
significantly
50
IJM Au(III).
influenced
by
MM.
Au(II1)
hPTH
5
observed
activity
to
effects
0.5
was
cyclase
concentrations
a
activity
l-34
50
loo
hPTH
l-34
on
adenylate
and
PGE2
cyclase are
500 bq/ml)
in
response
demonstrated
0
-6
in
-7
to Fig.
-6
2.
varying Au(II1)
-5
b
Fig. 2. Effect of A~(1111 on hPTH 1-34 and PGE2 stimulation of adenylate Values are expressed as per cent of maximal adenylate cyclase cyclase. activity. Maximal activities were (pm01 cAMP/min/mg): In the presence of 50 rig/ml hPTH I-34 and 200 flM GppNHp, control, 170; 0.25 pM Au(III), 212; 10 UM Au(III), 69; and in the presence of 100 pM PGE and 200 pM 68; 0.25 pM Au(III), 93; 10 )JM Au(III), $9. GppNHpGPPNHP, control, stimulated activity was substracted from each total activity.
-4 PGE2(M)
Vol. 130, No. 2, 1985
BIOCHEMICAL
1. Effect
Table
of
Au(III)
MIT*+ -dependent
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
and
NEM on hPTH
osteoblast
adenylate
cyclase
Adenylate (pm01
GppNHp-
activity
cyclase
CAMP/IO
and
activity
min/mg
of
protein)
Treatment
Control
Basal
None
120
-+ 9
483
-+
18
1432
-+
130
UM
126
-+ 6
471
-+ 20
1843
-+
197
NM
115
-+ 15
473
-+ 31
560
+ 63
UM
119
-+
17
492
-+ 23
1350
+ 101
UM
124
-+
11
488
-+ 35
612
Au(III)
0.25
Au(II1)
50
NEM
0.25
NEM
50
Osteoblast NEM and (basal) activity are the
tration
of hPTH
stimulate Au(II1)
concentration
nM) did
(10
constant
PTH + GppNHp
-+ 76
membranes were incubated for 30 min at 37°C with Au(III) or in the absence assayed for adenylate cyclase with 2 mM MnCl Control and presence of 50 rig/ml hPTH l-34 and 200 u i4 GppNHp. represents adenylate cyclase assayed with 2 mM MgC12. Values means -+ SEM of triplicate determinations.
at a stimulating
not
PM) and at an inhibiting
significantly
change
Similarly,
l-34.
adenylate
(0.25
cyclase
altered
concen-
the apparent
activation
constant
of PGE
the activation
was not
to
2
in the presence
of the
in the presence
of Mg
same
concentrations. The above experiments
co-factor strate
for the
were
carried
enzyme activity.
effects
of Au(II1)
recorded
on adenylate
cyclase
of Mn 2+ . Basal
the presence
of Mn 2+ as compared
high
(50 uM) concentrations
late
cyclase
inhibited presence tested
activity.
However,
was found to Mg
not
at 0.25
in osteoblast
cyclase,
however,
1,
the
as
1 demon-
higher (0.25
in in
pM) and
basal
activity
adeny-
and 50 uM in the
sulfhydryl
agent
Mn 2+ -dependent hPTH
2+
assayed
uM increased
membranes.
was inhibited 583
at low
cyclase
influence
activity
activity
Mn2+ -dependent
affect
in Table
in Table
to be 4-fold
. Au(II1)
adenylate
uM and 50 nM did not
cyclase
of adenylate
shown
2+
Au(III)
the hPTH I-34-sensitive
at 0.25
adenylate
activity
did
of Mn 2+ . As also
out
The results
the presence
tion
plus
l-34
l-34
NEM
basal stimula-
by NEM at 50 uM.
Vol.
130,
No. 2, 1985
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
10.
0-w
* 0
-7
-6
-6
-4
-5 concentration
(Ml
Fig. 3. Effects of Au(III) (O,O) and NEM (A,A) on GppNHp-activated (@,A) and on GppNHp-preactivated (O,A) adenylate cyclase. Assay conditions were as described under 'Methods'. Values represent the means of triplicate determinations in 2 separate experiments. The effect cyclase wing
of Au(II1)
by GppNHp and their
preactivation
Au(II1)
with
adenylate
at 0.25
preactivated
enzyme.
of Au(II1)
ted adenylate
of Au(II1) cyclase.
hPTH l-34
was completely
failed
in Fig.
3.
inhibited
In contrast,
GppNHp-
by Au(II1)
NEM inhibited
at the
GppNHp activation
to inhibit
on the hormone The data
responsiveness
reveal
that
and PGE2 stimulation
In the presence
of hPTH l-34
depicted
follo-
enzyme.
effects
both
activity
uM progressively
l-50
was not affected
adenylate
uM increased
are
activity.
Similarly,
2 shows the
of GppNHp-preactivated
tion
cyclase
the GppNHp-preactivated
Table
effect
from
of adenylate
cyclase
nucleotide
of cyclase
concentrations.
not
on adenylate
ranging
activation
preactivated indicated
effect
the guanine
at concentrations
GppNHp-mediated
but
and NEM on the activation
of 50 JJM Au(III), abolished.
of nucleotidethe stimulatory
The same high
PGE2 stimulation
Au(III)
concentra-
of GppNHp-preactiva-
cyclase. DISCUSSION
The results selectively
alters
described
in this
communication
agonist-sensitive
adenylate 584
show that cyclase
Au(II1)
activity
without
Vol.
130.
BIOCHEMICAL
No. 2, 1985
Table
2.
of Au(III)
Effect
in osteoblast
AND
BIOPHYSICAL
RESEARCH
on hormone sensitive
membranes pretreated
COMMUNICATIONS
adenylate
with
Adenylate
cyclase
GppNHp
cyclase
activity
(pm01 CAMP/IO min/mg of protein) Addition
No treatment
GPPNHP hPTH
+ GppNHp
l-34
0.25
423
-+ 23
419
1829
-+ 90
2323
653
-+ 73
867
PGE2 + GppNHp
)JM
50 UM Au(III)
+ 17
432
-+ 20
+ 108
490
-+ 52
-+ 58
747
-+
Au(III)
101
GppNHp-pretreated osteoblast membranes were treated for 30 min at 37°C of hPTH l-34, PGE2, and with Au(II1) prior to assay. The concentrations GppNHp were 50 rig/ml, 100 MM, and 200 uM, respectively. Values are the means -+ SEM of triplicate determinations.
affecting
basal
stimulated whereas Since its
enzyme activity.
hPTH I-34-induced it
changed
Au(II1) effects
at low
cyclase
consistent
with
regulatory
protein.
but
with
groups. basal
by our
adenylate
Furthermore,
experiments
cyclase effect preactivation
known that
is
and those
It
of GppNHp with
Identical
with
of other
of
This
is
nucleotide
that
for
Au(II1)
this
with
however,
the
view
has
added
(ll-
sulfhydryl
strongly
not
inhibit suppress
hormone.
GppNHp obstructed were
in
investigators
up to 50 uM, did
observations 585
guanine
Support
and without
of cyclase
forms
may be essential
irreversibly
did,
similarly,
as non-specific.
suggestion
that
mechanism.
NEM, tested
activity.
the
groups
to react
very
activated
on the
activity,
enzyme activity.
of the enzyme.
of Au(II1)
of our data
coupling
showed
of enzyme activity.
activity
uM, Au(III)
cyclase
be considered
the variosly
sulfhydryl
NEM, an agent
the activatory
tion
reactive
Our data
action
0.25
adenylate
GppNHp-dependent
must
the basal
aspect
receptor-cyclase
been provided 13)
not
below
and PGE2 stimulation
l-34
uM inhibited
a primary
with
nor
concentrations
An interesting interacts
basal hPTH
above 0.5
adenylate
and PGE2-induced
neither
influenced
Au(II1)
hormone
At concentrations
NEM inhibi-
made when GppNHp-
Vol.
130,
No. 2, 1985
preactivated
BIOCHEMICAL
enzyme was challenged
NEM confirm
those
by Au(II1)
is
groups
located
these
sulfhydryl
late act
cyclase at
cyclase.
of considerable the binding
adenylate
complex
less
inhibited
to its
to hPTH
receptor
to adenylate
and/or
cyclase
sulfhydryl
Presumably,
additive
not
perhaps
shown).
the response
of
to PGE2 is
selectively the
on
when
(data
but not
l-34
Au(II1)
cyclase,
with
then
at 50 uM fully
that
to NEM
of the two agents
inhibition
suggests
analogy
modifies
coupling
of the
by gold-sulfhydryl
at the receptor.
should
be stressed
gold-sulfhydryl
that
interactions
activated
adenylate
possible
mechanisms
from
general
molecular
It
dopamine-
and NEM probably
submaximal
cyclase
nucleus
and NEM when adeny-
effects were
with
adenylate
Au(II1)
inhibitory
COMMUNICATIONS
obtained
protein.
(14).
cyclase
Au(II1)
of hPTH l-34
PTH-receptor
our
the
giving
interest.
the
to Au(II1)
state
of adenylate
GppNHp-preactivated
exchange
since
that
if
of Au(III)
inaccessible
activated
at concentrations
Hence,
nucleotide-binding
are
in the
Our data
f or the caudate
an interaction
guanine
groups
RESEARCH
of the GppNHp-sensitive
with
on the
GppNHp stimulation
It
inhibition
consistent
The finding
Au(I.11).
adenylate
the same site,
combined
with (14)
the
is
BIOPHYSICAL
of Suen et al.
and GppNHp-sensitive may be extended,
AND
these
to account
for
they
cyclase, of Au(II1)
conclusion
entities
although
do not
action. that
However, is
have
the effects
exclude
Au(II1)
and interactions
studies
on
of Au(II1)
on
in any way other this
useful
responsible
focused
does not for
for
distract
elucidating
adenylate
the cyclase
activation.
ACKNOWLEDGEMENTS We thank Mrs. Ulrike This study was supported schaft (no. Ke 291/2-l).
Sch;ifer for her skilled technical assistance. by a grant from the Deutsche Forschungsgemein-
REFERENCES 1.
ROSS) E.M.
and Gilman,
A.G.
(1980)
Annu.
Rev.
Biochem.
533-564. 2.
Danpure,
C.J.
(1976)
Biochem.
Pharmacol.
2,
2343-2346.
49,
Vol.
130,
3. 4. 5. 6.
No. 2. 1985
8. 9.
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
Shaw, F.C. III (1979) Inorg. Perspect. Biol. Med. 2, 287-355. Buneaux, J.J., Buneaux, F. et Galmiche, P. (1975) Colloquia de 1'Institut National de la Recherche Medicale 40, 141-155. Kean, W.F., Kassam, Y.B., Lock, C.J.L., Buchanan, W.W., Rischke, and Nablo, L. (1984) Clin. Pharmacol. Ther. 35, 627-632. Hefley, T., Cushing, 3. and Brand, J.S. (1981) Am. J. Physiol. 24C&
7.
BIOCHEMICAL
J.
C234-C238.
NiIweide, P.J., van der Plas, A. and Scherft, J.P. (1981) Calcif. Tissue Int. 33, 529-540. Van Valen, F. and Schiitte, P.P. (1983) Proc. Kon. Ned. Akad. Wetensch. -B 86 401-415. -’ Heersche, J.N.M., Marcus, R. and Aurbach, G-D. (1974) Endocrinology 2,
241-247.
10. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) J. Biol. Chem. 2, 265-275. 11. Suen, E.T., Stefanini, E. and Clement-Cormier, Y.C. (1980) Biochem. Biophys. Res. Commun. 96, 953-960. 12. Stadel, J.M. and Lefkoztz, R.J. (1979) Mol. Pharmacol. 16, 709-718. 13. Schramm, M. and Naim, E. (1979) J. Biol. Chem. 245, 3225-3231. 14. Suen, E.T., Kwan, P.C.K. and Clement-Cormier, Y.C. (1982) Mol. Pharmacol. 2, 595-601.
587